Akèy › Metiyè › Biochemists and Biophysicists › Watertown, MA
Biochemists and Biophysicists nan Watertown, MA: Salè H-1B
43 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Watertown, MA. Salè baz medyàn ofri $127,858; mwatye mitan $110,000–$147,956.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $90,000 |
| Nivo II (kalifye) | $120,000 |
| Nivo III (eksperyans) | $140,200 |
| Nivo IV (plen kompetans) | $168,122 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Kymera Therapeutics, Inc. | 7 | $125,715 |
| Treeline Biosciences, Inc. | 5 | $120,000 |
| Arranta Bio MA LLC | 4 | $132,500 |
| Dyno Therapeutics, Inc. | 3 | $131,496 |
| Seismic Therapeutic Inc | 3 | $140,000 |
| Tome Biosciences Inc. | 3 | $130,000 |
| SQZ Biotechnologies Company | 2 | $100,000 |
| Affini-T Therapeutics, Inc. | 2 | $82,466 |
| Apellis Pharmaceuticals Inc. | 2 | $130,600 |
| Mariana Oncology, Inc. | 2 | $140,550 |
| Psivant Therapeutics, Inc. | 2 | $158,888 |
| Forma Therapeutics, Inc. | 1 | $68,000 |
| NanoTemper Technologies, Inc. | 1 | $90,000 |
| Landmark Bio PBLLC | 1 | $110,000 |
| Empress Therapeutics, Inc. | 1 | $90,000 |
| Prime Medicine, Inc. | 1 | $132,622 |
| Orna Therapeutics, Inc. | 1 | $161,330 |
| Souffle Therapeutics, Inc. | 1 | $174,915 |
| Eli Lilly and Company | 1 | $182,040 |
Tit travay
- Scientist II2
- Senior Scientist I2
- Principal Scientist2
- Research Associate II2
- Research Associate (Biotech)1
- Senior Research Associate II, Drug Discovery Biology1
- Senior Research Associate, Platform Biology1
- Analytical Development Scientist1
- Senior Scientist, Medicinal Chemistry1
- Scientist – High Throughput Screening1
- Sr. Scientist I, gRNA Process Development1
- Scientist I, Formulations Development1
- Associate Scientist, Platform Biology1
- Associate Scientist, Analytical Development1
- Senior Research Associate, Hematopoietic Stem Cell Therapy1
Pwonse H-1B nan Watertown, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).